Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer

NCT00735878 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped data from a similar did not show efficacy.

Conditions

Non Small Cell Lung Cancer
Lung Cancer

Interventions

DRUG: ABT-751 and Carboplatin

Sponsor

Konstantin Dragnev

Collaborators

[object Object]